Composition
- Active ingredients
- UMBRALISIB TOSYLATE EQ 200MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA213176.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ukoniq
- Active substance
- umbralisib tosylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- TG Theraps
- Status
- Discontinued
- FDA approval
- 5 Feb 2021
- Application
- NDA213176-001